THQ Insider Trading Activity and SEC Form 4 Filings
THQ insider trading summary
Over the past 12 months, insiders at abrdn Healthcare Opportunities Fund (THQ) reported 1 open-market purchase worth $11K by 1 insider and no sales on SEC Form 4. Net insider buying was $11K.
Latest THQ insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 16, 2026 | Chris LaVictoire Mahai | Director | Buy | $11K (568 @ $18.49) |
| Jul 16, 2024 | Rose DiMartino | Director | Buy | $21K (1,000 @ $21.30) |
| Apr 9, 2024 | Kathleen Goetz | Director | Buy | $12K (600 @ $19.54) |
| Jan 2, 2024 | Todd Reit | Director | Buy | $18K (1,000 @ $18.44) |
| Dec 28, 2023 | Bill Maher | Director | Buy | $18K (1,000 @ $18.25) |
| Mar 23, 2022 | Kathleen Goetz | Director | Buy | $2K (69.188 @ $21.68) |
| Jan 26, 2022 | Kathleen Goetz | Director | Buy | $10K (479 @ $21.73) |
| Feb 25, 2021 | William S Reardon | Director | Buy | $25K (1,196 @ $20.85) |
| Sep 23, 2020 | Jeffrey Allen Bailey | Director | Buy | $10K (570 @ $17.68) |
| Mar 17, 2020 | Daniel R Omstead | President | Buy | $107K (7,300 @ $14.67) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.